If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman ...

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...

PITTSBURGH (KFSN) -- As many as one million Americans are living with Parkinson's disease, a progressive movement disorder with no cure. Medications may help control the symptoms for a period of time, ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

A study found that a diabetes treatment DPP-4 inhibitor prevents Parkinson's disease from progressing.A research team led by ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

A new single-cell brain atlas reveals how midbrain neurons develop, helping refine Parkinson’s disease models and improve cell therapy protocols.

"I remember my right hand being able to move with much more ease once the stimulation was applied, and this in turn improved ...

A Northwestern Medicine research lab has found a usually harmless virus in brain samples from Parkinson’s patients. The idea that Parkinson’s could be linked to a virus had been theorized for years, ...

Meanwhile, beta blocker medications tend to reduce REM sleep, which is when most dreaming occurs, but research has found that ...